home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 26, 2019
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 537 active entries

Cook Pharmica

Bloomington, 46227
United States of America, Indiana
Toll free: 877-312-2665

Phone: 877-312-2665
Fax: 812-336-7167

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Cook Pharmica is a biopharmaceutical contract manufacturer of mammalian cell-culture products.  Cook Pharmica’s mission is to provide process development, flexible manufacturing and analytical services to the global biotech community; enabling our partners to bring their life saving discoveries to patients. Founded in 2004, Cook Pharmica is a privately held, wholly-owned subsidiary of Cook Group Incorporated.  Our current CGMP manufacturing and purification capacity is sized for clinical and small scale commercial runs (2 x 2500L bioreactors).  Our facility’s design incorporates disposable technologies, segregated production rooms, and a uni-directional flow of operators, equipment, and supplies to reduce the risk of contamination. Our manufacturing operations are highly automated and integrated. We offer contract development, purification, and analytical services in our laboratories for mammalian and microbial systems including CGMP cell bank storage. Our quality control analytical and microbiology labs also provide contract services.  Cook Pharmica offers a new level of transparency by giving clients the opportunity to monitor projects when away from the facility through secure Internet webcams positioned to give full visibility at each stage of production.  With a current facility of 124,000 square feet that is expandable to 450,000 square feet, and a second independent building with an additional 450,000 square feet, we are well positioned and committed to expand our production capacity and capabilities to meet the needs of our customers.

Selected Categories:

Product Company   Service Company
- General
- General
- Production
- Services

Last update of this entry: October 08, 2007

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.